Results 191 to 200 of about 2,522,370 (217)
Some of the next articles are maybe not open access.
Zoledronic Acid and Angiogenesis
Clinical Cancer Research, 2007To the Editors: In a recent issue of Clinical Cancer Research , Santini and co-workers ([1][1]) assert that zoledronic acid (ZA) may inhibit several antiangiogenic-related cascades and its metronomic administration could represent a new potential therapy targeting the endothelial-tumor ...
Gianluigi, Ferretti +6 more
openaire +2 more sources
Expert Opinion on Drug Safety, 2007
Zoledronic acid has been marketed for the past 5 years for the treatment of hypercalcemia of malignancy and malignant bone disease in patients with multiple myeloma or a broad range of solid tumors. The safety profile of zoledronic acid in this patient population is well established from the databases of several large, randomized, Phase III trials and ...
openaire +2 more sources
Zoledronic acid has been marketed for the past 5 years for the treatment of hypercalcemia of malignancy and malignant bone disease in patients with multiple myeloma or a broad range of solid tumors. The safety profile of zoledronic acid in this patient population is well established from the databases of several large, randomized, Phase III trials and ...
openaire +2 more sources